Application of myriocin to ND as well as to T2D islet cells led to compromised insulin secretion under low glucose conditions and a tendency to inhibiting both GSIS and KSIS that did not reach statistical significance (Fig 6A–6C). The gene discussed is INS; the disease is type 2 diabetes mellitus.